未登录 分享 收藏
Abexinostat, a histone deacetylases inhibitor, for patients with relapsed or refractory follicular lymphoma: a multi-center, single-arm phase 2 study 阿贝西替，一种组蛋白去乙酰化酶抑制剂，用于复发或难治性滤泡性淋巴瘤患者：一项多中心、单臂Ⅱ期研究 Gui, Lin; Liu, Haifeng; Wang, Huaqing; Cao, Junning; Li, Yufu; Yu, Yong; Gao, Yuhuan; Li, Zhenling; Shen, Jianzhen; Zhang, Lei; Zhang, Qingyuan; Pan, Hongming; Zheng, Meifang; Ke, Xiaoyan; He, Hesheng; Guo, Shuangshuang; Wang, Yihao; Xu, Xiaohong; Zou, Liqun; Wu, Wentao; Shi, Yuankai 分享 收藏
分享 收藏
分享 收藏
分享 收藏
Clinical, immune cell, and genetic features predicting survival and long-term response to first-line chemo-immunotherapy treatment for non-small cell lung cancer 临床、免疫细胞和遗传特征预测非小细胞肺癌患者对一线化疗免疫联合治疗的生存期和长期疗效 Huang, Liling; Zhu, Haohua; Dai, Liyuan; Feng, Yu; Chen, Xinrui; Xie, Zucheng; Hu, Xingsheng; Liu, Yutao; Hao, Xuezhi; Lin, Lin; Wang, Hongyu; Zhou, Shengyu; Yao, Jiarui; Tang, Le; Han, Xiaohong; Shi, Yuankai 分享 收藏
分享 收藏
Safety and efficacy of amulirafusp alfa (IMM0306), a fusion protein of CD20 monoclonal antibody with the CD47 binding domain of SIRPα, in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: a phase 1/2 study Yang, Jianliang; Song, Yongping; Zhou, Keshu; Li, Zhiming; Zhang, Mingzhi; Jing, Hongmei; Wang, Zhen; Yu, Li; Meng, Wei; Lu, Qiying; Tian, Wenzhi; Shi, Yuankai 分享 收藏
Finotonlimab with chemotherapy in recurrent or metastatic head and neck cancer: a randomized phase 3 trial Shi, Yuankai; Guo, Wei; Wang, Wei; Wu, Yunteng; Fang, Meiyu; Huang, Xiaoming; Han, Ping; Zhang, Qingyuan; Dong, Pin; Zhou, Xiaohong; Peng, Hanwei; Hu, Chunhong; Chen, Xiaopin; Zhang, Shurong; Chang, Zhiwei; Li, Xiaojiang; Ding, Yuhai; Qu, Song; Jing, Shanghua; Zhang, Songnan; Gui, Lin; Sun, Yan; Wang, Lin; Liu, Yanyan; Wu, Hui; Li, Guoqing; Fu, Zhichao; Shi, Jianhua; Jiang, Hao; Bai, Yuansong; Cui, Jiuwei; Zheng, Yulong; Cui, Wei; Jia, Xiaojing; Zhai, Limin; Cai, Qingqing; Xiong, Deming; Wu, Yunong; Cao, Junning; Wu, Rong; Hu, Guangyuan; Peng, Liang; Xie, Liangzhi; Gai, Wenlin; Wang, Yan; Su, Yuehua 分享 收藏
分享 收藏
Preliminary results from a phase I study of IMM0306 in patients with relapsed or refractory CD20-positive B-cell non-Hodgkin's lymphoma Shi, Yuankai; Yang, Jianliang; Song, Yongping; Zhou, Keshu; Li, Zhiming; Zhang, Mingzhi; Jing, Hongmei; Wang, Zhen; Yu, Li; Lu, Qiying; Gan, Frank; Tian, Wenzhi 分享 收藏
Sunvozertinib for patients in China with platinum-pretreated locally advanced or metastatic non-small-cell lung cancer and EGFR exon 20 insertion mutation (WU-KONG6): single-arm open-label, multicentre, phase 2 trial Wang, Mengzhao; Fan, Yun; Sun, Meili; Wang, Yongsheng; Zhao, Yanqiu; Jin, Bo; Hu, Ying; Han, Zhigang; Song, Xia; Liu, Anwen; Tang, Kejing; Ding, Cuimin; Liang, Li; Wu, Lin; Gao, Junzhen; Wang, Jianghong; Cheng, Ying; Zhou, Jianying; He, Yong; Dong, Xiaorong; Yao, Yu; Yu, Yan; Wang, Huijie; Sun, Si; Huang, Jianan; Fang, Jian; Li, Wen; Wang, Lin; Ren, Xiubao; Zhou, Chengzhi; Hu, Yanping; Zhao, Dahai; Yang, Runxiang; Xu, Fei; Huang, Yijiang; Pan, Yueyin; Cui, Jiuwei; Xu, Yan; Yang, Zhenfan; Shi, Yuankai 分享 收藏
Long-term outcomes with HLX01 (HanliKang®), a rituximab biosimilar, in previously untreated patients with diffuse large B-cell lymphoma: 5-year follow-up results of the phase 3 HLX01-NHL03 study Qin, Yan; Song, Yongping; Wang, Dong; Bai, Ou; Feng, Jifeng; Sun, Xiuhua; Qiu, Lihua; Yang, Jianmin; Yang, Yu; Wang, Zhao; Hu, Jianda; Wang, Huaqing; Su, Hang; Jin, Zhengming; Qian, Wenbin; Jin, Chuan; Zhang, Mingzhi; Yu, Ding; Liu, Li; Chen, Guoan; Li, Yarong; Sun, Tao; Jin, Jie; Bao, Huizheng; Du, Xin; Zhou, Hui; Fu, Gan; Shi, Yuankai 分享 收藏
Identification of novel prognostic autoantibodies in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone via a high-throughput antigen microarray Dai, Liyuan; Chen, Haizhu; Tan, Qiaoyun; Wang, Yanrong; Li, Lin; Lou, Ning; Fan, Guangyu; Xie, Tongji; Luo, Rongrong; Wang, Shasha; Zhou, Yu; Zhong, Qiaofeng; Yao, Jiarui; Zhang, Zhishang; Tang, Le; Shi, Yuankai; Han, Xiaohong 分享 收藏
Penpulimab combined with anlotinib in patients with R/M HNSCC after failure of platinum-based chemotherapy: a single-arm, multicenter, phase II study Shi, Y.; Gao, L.; Tian, Y.; Bai, C.; Chen, J.; Wang, J.; Li, X.; Zhang, C.; Sun, Y.; Su, H.; Liu, Z. 分享 收藏
Efficacy and safety of eribulin plus carboplatin combination for HER2-negative metastatic breast cancer Ni, M.; Zhou, L.; Lu, Y.; Zhang, L.; Li, X.; Chen, M.; Yang, A.; Zhang, L.; Xu, F.; Yuan, Z.; Wang, S.; Shi, Y.; An, X. 分享 收藏
Development and validation of a novel risk stratification model and a survival rate calculator for diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort study Zhong, Qiaofeng; Chen, Haizhu; Chen, Daoguang; Qin, Yan; He, Xiaohui; Yang, Yu; Yang, Jianliang; Liu, Peng; Zhou, Shengyu; Yang, Sheng; Zhou, Yu; Tang, Le; Chen, Chuanben; Shi, Yuankai 分享 收藏
Efficacy and safety of immunotherapy combined with single-agent chemotherapy as second- or later-line therapy for metastatic non-small cell lung cancer Chen, Dongna; Li, Lin; Wang, Mingzhao; Hu, Xingsheng; Jiang, Jun; Li, Weihua; Yang, Lin; Fan, Meng; Shi, Yuankai; Lv, Fang; Liu, Yutao 分享 收藏
Proteomics Identifies Circulating TIMP-1 as a Prognostic Biomarker for Diffuse Large B-Cell Lymphoma Lou, Ning; Wang, Guibin; Wang, Yanrong; Xu, Meng; Zhou, Yu; Tan, Qiaoyun; Zhong, Qiaofeng; Zhang, Lei; Zhang, Xiaomei; Liu, Shuxia; Luo, Rongrong; Wang, Shasha; Tang, Le; Yao, Jiarui; Zhang, Zhishang; Shi, Yuankai; Yu, Xiaobo; Han, Xiaohong 分享 收藏
Antibody response to SARS-CoV-2 WT and Omicron BA.4/5 of inactivated COVID-19 vaccine in patients with lung cancer after second and booster immunization 第二次和加强预防接种后肺癌患者对灭活新型冠状病毒肺炎疫苗SARS-CoV-2 WT和Omicron BA.4/5的抗体反应 Chen, Chen; Dai, Liyuan; Zheng, Cuiling; Li, Haolong; Li, Xiaomeng; Yang, Mengwei; Gao, Ruyun; Yao, Jiarui; Zhang, Zhishang; Shi, Yuankai; Han, Xiaohong 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
BIOMARKER RESEARCH.png)
OAAI
.png){kind=icon}
分享.png){kind=icon}
收藏